Avantor

AVTR · NYSE

$16.62+$0.33 (+2.03%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $16.29

Latest news

Press releaseOct 1, 6:05 AM ETPRNewswire
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026
NewsSep 30, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
Press releaseSep 21, 6:05 AM ETPRNewswire
Avantor appoints new Chief Financial Officer
NewsJul 29, 1:16 PM ETPiero Cingari
Oil Spikes 7%, Nasdaq 100 Sinks Before Fed: Stock Market Today
NewsJul 29, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
Press releaseJul 29, 6:05 AM ETPRNewswire
Avantor® Reports Second Quarter 2026 Results
Press releaseJul 14, 8:05 AM ETPRNewswire
Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product
Press releaseJul 1, 8:05 AM ETPRNewswire
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026
NewsMay 28, 8:01 AM ETAvi Kapoor
Braze Posts Mixed Q1 Results, Joins Sidus Space, Everpure And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Press releaseMay 19, 6:05 AM ETPRNewswire
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
NewsApr 29, 9:07 AM ET
Transcript: Avantor Q1 2026 Earnings Conference Call
NewsApr 29, 7:11 AM ET
Earnings Scheduled For April 29, 2026
NewsApr 29, 6:06 AM ET
Avantor Q1 Adj. EPS $0.17 Beats $0.16 Estimate, Sales $1.581B Beat $1.543B Estimate
Press releaseApr 29, 6:05 AM ETPRNewswire
Avantor® Reports First Quarter 2026 Results
Press releaseApr 23, 5:05 PM ETPRNewswire
Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer
Press releaseApr 21, 8:05 AM ETPRNewswire
Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing
NewsApr 13, 8:06 AM ET
Avantor Expands St. Louis Facility To Boost U.S. Biopharma Testing Speed And Supply Chain Efficiency
Press releaseApr 13, 8:05 AM ETPRNewswire
Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility
Press releaseApr 3, 8:05 AM ETPRNewswire
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
Press releaseApr 1, 8:00 AM ETPRNewswire
Avantor® Announces CFO Transition
NewsMar 25, 8:01 AM ETEva Mathew
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks
Press releaseMar 12, 10:29 AM ETGlobe Newswire
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Avantor, Inc. (AVTR), Baxter International Inc. (BAX), Biogen Inc. (BIIB), and CarMax, Inc. (KMX)
NewsMar 4, 12:41 PM ETErica Kollmann
Looking For A Rebound? China Tech and Emerging Markets Top Oversold List
NewsFeb 11, 2:23 PM ETPiero Cingari
Software Slump Resumes, Bitcoin Plunges To $66,000: What's Moving Markets Wednesday?
NewsFeb 11, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseFeb 11, 6:05 AM ETPRNewswire
Avantor® Reports Fourth Quarter and Full Year 2025 Results
Press releaseFeb 5, 10:50 AM ETGlobe Newswire
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Avantor, Inc. (AVTR), Baxter International Inc. (BAX), Biogen Inc. (BIIB), and CarMax, Inc. (KMX)
NewsFeb 1, 9:21 AM ETChris Katje
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Press releaseJan 28, 2:42 PM ETPRNewswire
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
Press releaseJan 12, 8:05 AM ETPRNewswire
Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026
Press releaseJan 5, 8:05 AM ETPRNewswire
Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference
Press releaseDec 29, 1:08 PM ETGlobe Newswire
AVANTOR FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Avantor Stockholders of the December 29th Deadline and Urges Investors to Contact the Firm
Press releaseDec 29, 10:18 AM ETBusiness Wire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit
Press releaseDec 29, 9:45 AM ETGlobe Newswire
Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors
Press releaseDec 29, 9:00 AM ETPRNewswire
The Gross Law Firm Notifies Shareholders of Avantor, Inc.(AVTR) of a Class Action Lawsuit and an Upcoming Deadline
Press releaseDec 26, 12:57 PM ETBusiness Wire
Deadline Soon: Avantor, Inc. (AVTR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
Press releaseDec 26, 10:20 AM ETGlobe Newswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
Press releaseDec 26, 9:00 AM ETPRNewswire
Investors in Avantor, Inc. Should Contact Levi & Korsinsky Before December 29, 2025 to Discuss Your Rights - AVTR
Press releaseDec 23, 10:38 AM ETPRNewswire
AVTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit
Press releaseNov 14, 9:26 AM ETGlobe Newswire
Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Maison Solutions Inc. (NASDAQ: MSS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
Press releaseNov 10, 9:42 AM ETGlobe Newswire
Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf
Press releaseNov 9, 8:34 PM ETGlobe Newswire
Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); Inspire Medical Systems, Inc. (NYSE: INSP); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf
NewsOct 17, 2:01 PM ET
P/E Ratio Insights for Avantor

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

10 Health Care Stocks With Whale Alerts In Today’s Session

Avantor appoints new Chief Financial Officer

Oil Spikes 7%, Nasdaq 100 Sinks Before Fed: Stock Market Today

12 Health Care Stocks Moving In Wednesday's Intraday Session

Avantor® Reports Second Quarter 2026 Results

Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product

Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026

Braze Posts Mixed Q1 Results, Joins Sidus Space, Everpure And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory

Transcript: Avantor Q1 2026 Earnings Conference Call

Earnings Scheduled For April 29, 2026

Avantor Q1 Adj. EPS $0.17 Beats $0.16 Estimate, Sales $1.581B Beat $1.543B Estimate

Avantor® Reports First Quarter 2026 Results

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer

Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing

Avantor Expands St. Louis Facility To Boost U.S. Biopharma Testing Speed And Supply Chain Efficiency

Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility

Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026

Avantor® Announces CFO Transition

EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Avantor, Inc. (AVTR), Baxter International Inc. (BAX), Biogen Inc. (BIIB), and CarMax, Inc. (KMX)

Looking For A Rebound? China Tech and Emerging Markets Top Oversold List

Software Slump Resumes, Bitcoin Plunges To $66,000: What's Moving Markets Wednesday?

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Avantor® Reports Fourth Quarter and Full Year 2025 Results

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Avantor, Inc. (AVTR), Baxter International Inc. (BAX), Biogen Inc. (BIIB), and CarMax, Inc. (KMX)

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm

Avantor® to Report Fourth Quarter and Full Year 2025 Earnings on Wednesday, February 11, 2026

Avantor® to Participate in 44th Annual J.P. Morgan Healthcare Conference

AVANTOR FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Avantor Stockholders of the December 29th Deadline and Urges Investors to Contact the Firm

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors

The Gross Law Firm Notifies Shareholders of Avantor, Inc.(AVTR) of a Class Action Lawsuit and an Upcoming Deadline

Deadline Soon: Avantor, Inc. (AVTR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor

Investors in Avantor, Inc. Should Contact Levi & Korsinsky Before December 29, 2025 to Discuss Your Rights - AVTR

AVTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Avantor Investors Have Opportunity to Lead Class Action Lawsuit

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Maison Solutions Inc. (NASDAQ: MSS); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Five Below, Inc. (NASDAQ: FIVE); Molina Healthcare, Inc. (NYSE: MOH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

Important Notice to Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR); Humana Inc. (NYSE: HUM); Inspire Medical Systems, Inc. (NYSE: INSP); and Maison Solutions Inc. (NASDAQ: MSS): Grabar Law Office Investigates Claims on Your Behalf

P/E Ratio Insights for Avantor